findmyKOL

Andrew Fiedler, MD

Basic profile

Rutgers

ORCIDNone on fileNPI
RegionSouth Bend, IN · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Andrew Fiedler is a Cardiology physician affiliated with Rutgers. OpenAlex indexes 9 publications with 1,337 citations (h-index 2).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
9publications

Distinct works indexed by OpenAlex.

1,337citations

Total citations across indexed works.

2h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

615 N Michigan St
South Bend, IN 466011033

Telephone

574-647-1000

Provider last certified this registry record 20 Dec 2024.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    81.5%
    Beta blocker20%
    Metoprolol Succinate36%Metoprolol Tartrate28%Carvedilol18%Atenolol7%Sotalol6%Nebivolol Hcl2%Bisoprolol Fumarate2%Labetalol Hcl2%
    Part D<11 patients
    Statin17.8%
    Atorvastatin Calcium68%Rosuvastatin Calcium25%Pravastatin Sodium3%Simvastatin3%
    Part D<11 patients

    + 17 more classes in this area

  • Blood & clotting

    15.6%
    Factor Xa inhibitor11.2%
    Eliquis75%Xarelto25%
    Part D84 patients
    P2Y12 inhibitor2.5%
    Clopidogrel100%
    Part D33 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.8%
    Potassium supplement2.4%
    Potassium Chloride89%Klor-Con M2011%
    Part D<11 patients
    Proton pump inhibitor0.4%
    Pantoprazole Sodium100%
    Part D<11 patients
Where care is delivered (Part B)6.3% facility · 93.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”